We recently showed abundant expression of UGT genes in human cancers and their association with clinical outcomes, highlighting the importance of the intratumoral metabolism of drugs and pro/anti-cancer signaling molecules through the UGT conjugation pathway [39]. Here, SLC35A2 is linked to cancer.